Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke
Authors:
- 29 August 2013
- journal article
- clinical trial
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 25 (11) , 896-e702
Abstract
In a previous pilot study, we demonstrated that a single injection of botulinum toxin A (BTX-A) in the cricopharyngeus muscle is effective in patients with neurologic dysphagia with upper esophageal sphincter (UES) opening dysfunction and presence of some pharyngeal contraction (>25 mmHg). The aim of this study was to confirm the long-lasting efficacy of this procedure after stroke. We prospectively studied 23 patients with stroke for at least 6 months before administration of a BTX-A injection. Baseline diagnosis of UES opening dysfunction and presence of some pharyngeal contraction were assessed by videofluoroscopy (VFS) and esophageal manometry (EM). Clinical and VFS follow-up was made at 3 weeks and 3, 6, and 12 months postinjection. Eighteen patients (78%) were fed by gastrostomy tube prior to treatment. Videofluoroscopy showed UES relaxation impairment, residue in pyriform sinuses, and aspiration in all cases. After BTX-A, the number of patients with aspiration and pharyngeal residue decreased to 52% and 70%, respectively (p < 0.05 for both); residue was severe in only 4%. Esophageal manometry showed a mean pharyngeal amplitude 66.8 mmHg (range: 25-120 mmHg). We observed a significant improvement in feeding mode during follow-up: after 3 months, 70% of patients were eating exclusively by mouth. Lower residual pressure and minor pharyngeal delay time at baseline were all predictive factors for treatment effectiveness. A single injection of BTX-A is efficacious for a period of at least 12 months in improving oropharyngeal dysphagia in stroke patients with UES opening dysfunction and some pharyngeal contraction (>25 mmHg).Keywords
This publication has 42 references indexed in Scilit:
- Evolution of tracheal aspiration in severe traumatic brain injury‐related oropharyngeal dysphagia: 1‐year longitudinal follow‐up studyNeurogastroenterology & Motility, 2009
- Botulinum Toxin A Treatment of Cricopharyngeal Dysphagia After Subarachnoid HemorrhageDysphagia, 2008
- Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: A pilot studyScandinavian Journal of Gastroenterology, 2008
- Dysphagia in stroke patientsPostgraduate Medical Journal, 2006
- Swallowing and StrokeCerebrovascular Diseases, 2002
- Achalasia treatment in the elderly: is botulinum toxin injection the best option?European Journal of Gastroenterology & Hepatology, 2002
- Efficacy of Botulinum Toxin A for Treatment of Upper Esophageal Sphincter DysfunctionThe Laryngoscope, 2000
- Five‐year experience in the treatment of focal movement disorders with low‐dose dysportTM botulinum toxinMuscle & Nerve, 1995
- Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spreadHead & Neck, 1990
- Pharyngeal plexus neurectomy for alaryngeal speech rehabilitationThe Laryngoscope, 1986